Fairvalue-Calculator Fairvalue-Calculator
EN DE

ViGenCell Inc (308080) Fair Value & Analysis

Healthcare · KR · Market cap 190B KRW

Price6,610 KRW
Fair Value3,848 KRW
Upside-41.8%
Quality95/100
Evidence: Low Range 2,886 KRW – 4,811 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

ViGenCell Inc (308080) currently trades at 6,610 KRW, while our model-based Fair Value estimate is 3,848 KRW — implying the stock looks roughly 41.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

ViGenCell Inc. provides immune cell therapy in South Korea. It develops ViTier, an antigen-specific killer T cell therapy, such as VT-EBV-N for NK/T Lymphoma indications and VT-Tri(1)-A for AML indications; ViMedier, a cord blood-derived myeloid suppressor cell therapy, including VM-GD for GvHD indications and VM-AD for atopic dermatitis indications; and ViRanger, an off-the-shelf allogenic universal T cell gene therapy comprising VR-CAR and VR-GDT for hepatoma and leukemia indications. The company was founded in 2013 and is based in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is ViGenCell Inc (308080) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 3,848 KRW versus a price of 6,610 KRW — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 308080?
Our 21-model fair value for ViGenCell Inc is 3,848 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 6,610 KRW.
What is the quality score of 308080?
ViGenCell Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.